FIR Capital

Description
World´s fourth largest producer of human insulin. Sold to Novo Nordisk (NYSE: NVO).

Last Update on November 30, 2012

About Us	Team	Entrepreneur	Funds	Portfolio
FIR Capital Success Stories	Management Corporate Governance Body	Venture Capital For Entrepreneurs		Direct Investments Investments via Funds